News

Guideline update shortens minimum DAPT duration in CAD

Publish date: March 29, 2016

 

FROM THE JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

References

Dr. Bates reported consulting relationships with Merck and AstraZeneca. Eight other coauthors disclosed financial relationships with a number of pharmaceutical or device companies. Dr. Glenn Levine and seven coauthors disclosed no relationships with industry.

Pages

Recommended Reading

Periop statins don’t prevent acute kidney injury after cardiac surgery
MDedge Cardiology
VIDEO: A better way to treat large intraventricular hemorrhages
MDedge Cardiology
ISC: Thrombectomy shown highly cost-effective for stroke
MDedge Cardiology
Safety of bioresorbable stents does not match that of metal stents
MDedge Cardiology
Risk-prediction tool for early TAVR mortality
MDedge Cardiology
VIDEO: Ischemic-stroke thrombectomy use widens and refines
MDedge Cardiology
Age over 80 years should not preclude stenting of left main artery
MDedge Cardiology
High false positives found for Medtronic’s implantable AF detectors
MDedge Cardiology
Sutureless AVR an option for higher-risk patients
MDedge Cardiology
Study: Tricuspid annuloplasty with mitral replacement appeared safe and effective
MDedge Cardiology